NPI: 1730720665 · AUSTIN, TX 78753 · Federally Qualified Health Center (FQHC) · NPI assigned 10/02/2019
Authorized official SLOAN, JOY controls 19+ related entities in our dataset. Read more
| Authorized Official | SLOAN, JOY (CFO) |
| NPI Enumeration Date | 10/02/2019 |
Other providers sharing the same authorized official: SLOAN, JOY
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 5,792 | $380K |
| 2020 | 38,113 | $2.17M |
| 2021 | 90,139 | $5.34M |
| 2022 | 73,979 | $5.04M |
| 2023 | 73,949 | $5.15M |
| 2024 | 76,694 | $5.54M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 72,583 | 60,571 | $16.05M |
| D0999 | Unspecified diagnostic procedure, by report | 12,213 | 11,899 | $3.16M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26,647 | 23,931 | $753K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6,650 | 6,439 | $543K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5,645 | 1,634 | $537K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6,655 | 6,399 | $445K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7,535 | 7,269 | $428K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10,315 | 9,415 | $369K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7,088 | 6,848 | $367K |
| 99381 | 1,457 | 1,403 | $210K | |
| 87428 | 8,122 | 7,463 | $198K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,264 | 445 | $129K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 12,175 | 11,256 | $82K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3,133 | 2,924 | $57K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,523 | 2,379 | $47K |
| 99383 | 757 | 734 | $43K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9,229 | 4,375 | $37K |
| 99384 | 543 | 524 | $35K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 6,672 | 5,679 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,295 | 2,100 | $16K |
| 90832 | Psychotherapy, 30 minutes with patient | 408 | 360 | $13K |
| 99382 | 214 | 214 | $13K | |
| 92523 | 47 | 43 | $7K | |
| 90834 | Psychotherapy, 45 minutes with patient | 159 | 146 | $6K |
| 90461 | 1,706 | 1,202 | $6K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 561 | 555 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 90 | 77 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15,126 | 14,533 | $4K |
| 0001A | 398 | 354 | $3K | |
| 0002A | 172 | 146 | $3K | |
| 81002 | 1,494 | 1,403 | $2K | |
| 96160 | 2,038 | 1,998 | $2K | |
| 90620 | 1,619 | 1,557 | $2K | |
| 0071A | 70 | 68 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 17,534 | 9,129 | $2K |
| 96380 | 207 | 204 | $1K | |
| 99429 | 76 | 76 | $1K | |
| D1120 | Prophylaxis - child | 6,456 | 6,352 | $845.25 |
| 99215 | Prolong outpt/office vis | 14 | 14 | $824.00 |
| D0120 | Periodic oral evaluation - established patient | 5,937 | 5,850 | $807.80 |
| 92552 | 391 | 382 | $653.01 | |
| 90480 | 44 | 43 | $600.00 | |
| D1351 | Sealant - per tooth | 3,566 | 788 | $593.04 |
| 90619 | 1,393 | 1,350 | $421.19 | |
| 96158 | 61 | 52 | $360.00 | |
| D0272 | Bitewings - two radiographic images | 3,674 | 3,562 | $327.32 |
| D0145 | Oral evaluation for a patient under three years of age | 2,847 | 2,807 | $320.00 |
| 92551 | 1,496 | 1,476 | $293.68 | |
| 0051A | 13 | 12 | $280.00 | |
| 81003 | 182 | 173 | $226.31 | |
| D1206 | Topical application of fluoride varnish | 7,143 | 7,042 | $205.80 |
| D0240 | 8,398 | 4,052 | $166.60 | |
| D1110 | Prophylaxis - adult | 931 | 920 | $164.64 |
| D2930 | Prefabricated stainless steel crown - primary tooth | 792 | 172 | $149.12 |
| D7140 | Extraction, erupted tooth or exposed root | 33 | 14 | $128.12 |
| 90474 | 1,618 | 1,568 | $124.56 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 789 | 766 | $124.00 |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 13 | 13 | $112.00 |
| 94760 | 148 | 144 | $85.50 | |
| D0220 | Intraoral - periapical first radiographic image | 496 | 396 | $75.36 |
| D0210 | Intraoral - complete series of radiographic images | 101 | 101 | $70.64 |
| D0274 | Bitewings - four radiographic images | 638 | 637 | $69.22 |
| J3535 | Drug administered through a metered dose inhaler | 15 | 15 | $66.72 |
| 90734 | 1,356 | 1,271 | $38.98 | |
| D0140 | Limited oral evaluation - problem focused | 219 | 214 | $37.56 |
| D0150 | Comprehensive oral evaluation - new or established patient | 468 | 458 | $35.32 |
| 90633 | 3,395 | 3,292 | $24.52 | |
| 90698 | 1,903 | 1,841 | $23.95 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1,833 | 1,757 | $11.93 |
| D0230 | Intraoral - periapical each additional radiographic image | 279 | 114 | $11.51 |
| 90686 | 7,035 | 6,878 | $7.61 | |
| 90670 | 2,896 | 2,814 | $7.14 | |
| 96161 | 1,189 | 1,092 | $2.53 | |
| D0603 | 7,599 | 7,475 | $0.02 | |
| D0602 | 1,059 | 1,050 | $0.01 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 1,362 | 1,350 | $0.00 |
| 90381 | 119 | 117 | $0.00 | |
| 90723 | 2,729 | 2,646 | $0.00 | |
| 90744 | 1,086 | 1,044 | $0.00 | |
| 90696 | 1,089 | 1,052 | $0.00 | |
| 36416 | 961 | 871 | $0.00 | |
| 90677 | 1,553 | 1,492 | $0.00 | |
| 90651 | 2,635 | 2,546 | $0.00 | |
| D0601 | 1,035 | 1,023 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 14 | 13 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 885 | 851 | $0.00 |
| 90716 | 1,398 | 1,356 | $0.00 | |
| 91307 | 153 | 150 | $0.00 | |
| D9420 | 150 | 95 | $0.00 | |
| 90656 | 687 | 681 | $0.00 | |
| 91305 | 115 | 106 | $0.00 | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 294 | 103 | $0.00 |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 323 | 83 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 13 | 13 | $0.00 |
| D1208 | Topical application of fluoride, excluding varnish | 47 | 47 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | 13 | $0.00 |
| 96127 | 25 | 24 | $0.00 | |
| 90688 | 37 | 37 | $0.00 | |
| A9150 | Non-prescription drugs | 14 | 13 | $0.00 |
| 90648 | 3,934 | 3,817 | $0.00 | |
| 90671 | 1,698 | 1,660 | $0.00 | |
| 90710 | 1,266 | 1,221 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 1,546 | 1,534 | $0.00 |
| 90700 | 976 | 948 | $0.00 | |
| 91300 | 631 | 522 | $0.00 | |
| 90681 | 2,686 | 2,612 | $0.00 | |
| 90707 | 1,243 | 1,204 | $0.00 | |
| 99173 | 2,551 | 2,485 | $0.00 | |
| 90715 | 1,629 | 1,551 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 85 | 85 | $0.00 |
| 90649 | 135 | 130 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 92 | 92 | $0.00 |
| 90655 | 71 | 71 | $0.00 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 273 | 258 | $0.00 |
| 90713 | 56 | 56 | $0.00 | |
| 90380 | 82 | 78 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 108 | 37 | $0.00 |
| 90658 | 27 | 27 | $0.00 |